GeneTex

  • Country / Location Selection

United States (US)

Activin Receptor Type IA blocking peptide

Cat. No. GTX31779-PEP

Application

 Neutralizing/Inhibition
Package
50 μg ($139)
See all Activin Receptor Type IA products
PRODUCT

Summary

Activin Receptor Type IA peptide is used for blocking the activity of Activin Receptor Type IA antibody (catalog number GTX31779).

APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.
Application Recommended Dilution
Neutralizing/Inhibition Assay dependent
Not tested in other applications.

PROPERTIES

Form

Liquid

Buffer

PBS, 0.1% BSA

Preservative

0.02% Sodium azide

Storage

Store as concentrated solution. Aliquot and store at -20ºC or below. Avoid freeze-thaw cycles.

Concentration

200 μg/ml (Please refer to the vial label for the specific concentration.)

Conjugation

Unconjugated

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

Activin A Receptor Type 1 , Actri , Acvr1A , Acvrlk2 , Alk2 , Fop , Skr1 , Tsri , Acvr1

Background

Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I ( I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. This gene encodes activin A type I receptor which signals a particular transcriptional response in concert with activin type II receptors. Mutations in this gene are associated with fibrodysplasia ossificans progressive. [provided by RefSeq, Jul 2008]

Research Area

REFERENCE

There are currently no references for Activin Receptor Type IA blocking peptide (GTX31779-PEP). Be the first to share your publications with this product.
Submit a Reference

REVIEW

There are currently no reviews for Activin Receptor Type IA blocking peptide (GTX31779-PEP). Be the first to share your experience with this product.
Submit a Review
SDS
PBS.pdf
Sodium Azide.pdf
Package List Price ($)
$ 139